Skip to the shortlist
Peptide ClarityGuide
Cost

Tesamorelin cost: brand-only pricing, insurance, and why there's no cheap version

There's one maker, one brand and no cheaper copy. That shapes every part of what you'd pay.

Nina Calder

Heads up: Peptide Clarity Guide works with partners, and a few buttons below pay us if you join (you pay the same). Who pays plays no part in the order here, or in what we write. How we earn.

The short answer

Approved tesamorelin products are brand Egrifta (SV or WR), so what you pay depends mostly on insurance coverage for its approved use, HIV-associated abdominal fat. There's no generic and, since March 2020, no lawful compounded version. Cheap research vials aren't a legal option for people.

Key takeaways

  • Ordinary approved tesamorelin prescriptions use brand Egrifta, with one maker, no generic and no approved biosimilar.
  • Since March 23, 2020, no pharmacy can legally compound it, so there's no lower-cost compounded version.
  • What you pay mostly depends on whether your plan covers its one approved use, belly fat in adults with HIV.
  • The maker runs co-pay help for commercial insurance and a no-cost program for patients who qualify.
  • The effect faded within six months of stopping in the trials, so discuss the cost of continued treatment and reassessment.

Here's the short version. Tesamorelin has approved brand Egrifta formulations, and one maker. The maker doesn't post a list price on its Egrifta pages right now. Your number comes from your insurance and the maker's support program, not a price tag [5].

Five ways tesamorelin is offered, and what sets the cost of each

The ordinary prescription routes below use the approved brand; investigational access follows separate rules. The table shows what decides your cost on each one.

Every way tesamorelin is offered, and what determines its cost.
RouteLegal for you?What sets the priceTypical coverage
Egrifta SV or WR, with insuranceYes, with a prescriptionYour plan's drug tier and any approval it requiresTied to the approved use in adults with HIV
Egrifta, paying cashYes, with a prescriptionThe pharmacy's cash price; the maker posts no list priceNone
The maker's support programYes, if you qualifyProgram rules: co-pay help for commercial plans, a no-cost program for qualifying patients [5]Works alongside your plan
Compounded tesamorelinNo: no 503A or 503B route since March 23, 2020 [2]Not a legal productNone
"Research use only" vialsNoNot a drug for peopleNone

If you came here because you saw a low monthly figure, check which row it belongs to. The route itself is explained in whether you can get tesamorelin legally.

Brand-only availability limits the comparison

Tesamorelin has one maker, no generic and no lawful compounded copy, because FDA moved it to the biologics framework on March 23, 2020. On that date it left FDA's list of ordinary drugs and joined the list of licensed biologics [1].

That move matters for price in two ways. First, compounding pharmacies lost the legal right to make it [2]. Second, a cheaper copy of a biologic has to come through FDA's biosimilar pathway. FDA's current list of approved biosimilars has none for tesamorelin [3].

Then there's the drug's niche. Egrifta is approved for one condition, belly fat in adults with HIV and lipodystrophy [4].

The maker doesn't post a list price, so your number depends on your coverage

Theratechnologies doesn't publish a list price on its Egrifta pages right now. Pharmacies set their own cash prices. Our advice: ask for the cash price in writing before you fill.

You'll often see a dollar figure for tesamorelin online. Before you trust one, ask three questions:

  1. Is it for brand Egrifta, or for a compounded or research product with no legal route?
  2. Which version, SV or WR? They aren't interchangeable, and each needs its own prescription [4].
  3. Is it a pharmacy's quote, or someone's estimate? Only your pharmacy's quote is your price.

Insurance coverage depends on your plan and the approved use

Coverage depends on your plan and is generally tied to Egrifta's approved use. That's reducing excess abdominal fat in adults with HIV-associated lipodystrophy [4].

Egrifta is filled through specialty pharmacies, and the maker's program checks your benefits before your first shipment [6]. Here's what to ask your prescriber's office:

  • Does my plan need prior approval for Egrifta, and what does it ask for?
  • Which specialty pharmacy is in my network?
  • What will my co-pay be each month after the plan pays?
  • If the plan says no, can we appeal, and what would the appeal need?

Five things that change what you pay each month

Two people with the same prescription can pay very different amounts. These are the levers, to review with your plan and pharmacy:

  1. Your deductible. Early in the plan year you may pay far more until it's met. Ask when yours resets.
  2. The drug tier. Plans sort drugs into tiers, and some tiers charge a percentage of the price instead of a flat co-pay. Your plan's drug list shows where Egrifta sits.
  3. Which version is prescribed. Egrifta SV and Egrifta WR aren't interchangeable, so a switch means a new prescription and possibly a fresh coverage check [4].
  4. Visits and labs. Ask whether follow-ups and IGF-1 and blood sugar tests are billed separately or included.
  5. Tax-advantaged money. IRS rules count prescribed drugs as medical expenses, so an Egrifta fill generally qualifies for HSA or FSA funds [7]. Your plan administrator has the final word.

The maker runs co-pay help and a no-cost program for patients who qualify

Theratechnologies runs a support program, THERA patient support, for people prescribed Egrifta WR. It covers money questions as well as the practical ones [5].

  • Commercial insurance: you may qualify for its co-pay assistance program.
  • Government insurance: the program offers information and resources that may lower your costs.
  • Patient assistance: qualifying patients can get the medicine at no cost.
  • Coverage help: coordinators check your benefits and find a specialty pharmacy in your network.

Your prescriber enrolls you, and you give consent as part of that form [6]. Eligibility rules are the program's own, so ask the coordinator what applies to you.

Discuss ongoing cost and reassessment

In the trials, the benefit faded when people stopped. Those switched to placebo at 26 weeks saw deep belly fat rise 16% to 22% over the next six months [4].

Lab work is part of the running cost too. Your prescriber will track IGF-1, which rose 81% on the drug versus a 5% fall on placebo in the main trial [8]. Ask whether those blood tests are billed separately.

So budget for the treatment as ongoing, not a one-time course. The full trial timeline is in how long tesamorelin takes to work. If you're paying with a muscle goal in mind, read does tesamorelin build muscle first; the effect was small.

Compounded and research prices aren't real options

Prices you see for compounded tesamorelin or research vials are for products with no lawful route to you. A clinic menu or a vial site can quote a figure. That doesn't make it a legal product.

The same goes for blends. A pre-mixed tesamorelin and ipamorelin product has no legal source either; tesamorelin and ipamorelin together explains why.

If the goal is belly fat or weight, GLP-1 programs are the legal options most people compare; start with our metabolic shortlist. They're approved or prescribed for weight, which Egrifta isn't.

For growth-hormone support, sermorelin is prescribed as a compounded drug and priced very differently. See what sermorelin costs. Compounded drugs aren't FDA-approved, so ask your prescriber what that means for you.

Frequently asked

Is tesamorelin covered by insurance?
Coverage depends on your plan and is generally tied to Egrifta's approved use in adults with HIV-associated lipodystrophy. Your prescriber's office can check whether prior approval is needed. The maker's support program also checks benefits.
Why is tesamorelin so expensive?
It's a brand-only biologic with a single maker, no generic and no lawful compounded version since March 2020. No approved biosimilar competes with it.
Is there a cheaper generic tesamorelin?
No. No generic or biosimilar tesamorelin is approved in the US right now.
Is compounded tesamorelin cheaper?
Compounded tesamorelin has no lawful route in the US. FDA treats Egrifta as a biologic, and biologics on its 2020 transition list can't be compounded under 503A or 503B.
How much does tesamorelin raise growth hormone?
In the main approval trial, IGF-1, the hormone that growth hormone drives, rose 81% on tesamorelin versus a 5% fall on placebo over 26 weeks. The label asks prescribers to monitor it during treatment.

Sources

  1. [1] List of Approved NDAs for Biological Products That Were Deemed to be BLAs on March 23, 2020. FDA
  2. [2] Notice to Compounders: Changes that affect compounding as of March 23, 2020. FDA
  3. [3] FDA: Biosimilar Product Information (content current as of October 5, 2026) (2026). FDA
  4. [4] Egrifta WR (tesamorelin) for injection, prescribing information (2025). DailyMed label
  5. [5] Theratechnologies: THERA patient support program (2026). Company website
  6. [6] Theratechnologies: THERA patient support, how the program works (2026). Company website
  7. [7] IRS Publication 502: Medical and Dental Expenses (Medicines) (2025). Source
  8. [8] Falutz J. Metabolic effects of a growth hormone-releasing factor in patients with HIV (2007). PMID 18057338

Related research